Replies to post #4812 on Halozyme Therapeutics Inc (HALO)

[biotech2020]

FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab, http://finance.yahoo.com/news/fda-accepts-genentechs-biologics-license-123000219.html

[maumar]

It looks like Mabthera SC will be approved in 2017 and that should make a huge difference.